Literature DB >> 29243847

Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.

Ilhan Sanverdi1, Cetin Kilicci1, Ebru Cogendez1, Cigdem Abide Yayla1, Enis Ozkaya1.   

Abstract

BACKGROUND: There are very few biomarkers available to diagnose cases with premature ovarian failure. Some complete blood count parameters have been introduced to be diagnostic biomarkers for several disorders associated with inflammatory process. Due to the evidence that indicated chronic inflammatory process to be underlying pathophysiology in premature ovarian insufficiency (POI), we aimed to assess the predictive value of complete blood count parameters for POI diagnosis.
METHOD: A total of 96 women diagnosed to have premature ovarian failure were compared with 110 otherwise healthy women in terms of some basal hormone levels and complete blood count parameters.
RESULTS: Mean age was similar between groups. Neutrophil/lymphocyte and mean platelet volume/lymphocyte ratios were significantly higher in group with POI (P < .001, P < .003, respectively). In group with POI, there were significant correlations between anti-Mullerian hormone and follicle stimulating hormone (r = -.30, P <.05), anti-Mullerian hormone and white blood cell count (r = .23, P < .05). Mean platelet volume/lymphocyte ratio significantly predicted cases with POI (AUC = 0.607, %95 CI: 0.529-0.684; P < .001).
CONCLUSIONS: Neutrophil/lymphocyte and mean platelet volume/lymphocyte ratios are elevated in POI. There have been some controversies about the value of neutrophil/lymphocyte in POI diagnosis. We suggest mean platelet volume/lymphocyte ratio as a new biomarker in early POI because it is cheap and easily accessible compared to anti-Mullerian hormone.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-Mullerian hormone; inflammation markers; premature ovarian insufficiency

Mesh:

Substances:

Year:  2017        PMID: 29243847      PMCID: PMC6817150          DOI: 10.1002/jcla.22372

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  29 in total

Review 1.  Premature ovarian failure.

Authors:  Apollo Meskhi; Mourad W Seif
Journal:  Curr Opin Obstet Gynecol       Date:  2006-08       Impact factor: 1.927

2.  Association between some inflammatory markers and primary ovarian insufficiency.

Authors:  Gülçin Yldrm; Aytekin Tokmak; Mahmut Kuntay Kokanal; Esma Sarkaya; Cevdet Züngün; Hasan Ali İnal; Fatma Meriç Ylmaz; Nafiye Ylmaz
Journal:  Menopause       Date:  2015-09       Impact factor: 2.953

3.  Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas.

Authors:  Suleyman Baldane; Suleyman H Ipekci; Mehmet Sozen; Levent Kebapcilar
Journal:  Asian Pac J Cancer Prev       Date:  2015

Review 4.  Anti-Müllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker.

Authors:  Axel P N Themmen
Journal:  J Natl Cancer Inst Monogr       Date:  2005

5.  Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer.

Authors:  Serta Kılınçalp; Fuat Ekiz; Omer Başar; Mehmet Raşit Ayte; Sahin Coban; Barış Yılmaz; Akif Altınbaş; Nurcan Başar; Bora Aktaş; Yaşar Tuna; Halil Erbiş; Engin Uçar; Elife Erarslan; Osman Yüksel
Journal:  Platelets       Date:  2013-03-28       Impact factor: 3.862

6.  Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.

Authors:  Antonio La Marca; Stefania Marzotti; Annalisa Brozzetti; Gaspare Stabile; Alfredo Carducci Artenisio; Vittorio Bini; Roberta Giordano; Annamaria De Bellis; Annibale Volpe; Alberto Falorni
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

7.  Mean platelet volume/platelet count ratio in hepatocellular carcinoma.

Authors:  Sun Young Cho; John Jeongseok Yang; Eunkyoung You; Byung-Ho Kim; Jaejun Shim; Hee Joo Lee; Woo-In Lee; Jin-Tae Suh; Tae Sung Park
Journal:  Platelets       Date:  2012-07-26       Impact factor: 3.862

Review 8.  Genetic disorders in premature ovarian failure.

Authors:  T Laml; O Preyer; W Umek; M Hengstschlager; H Hanzal
Journal:  Hum Reprod Update       Date:  2002 Sep-Oct       Impact factor: 15.610

9.  ESHRE Guideline: management of women with premature ovarian insufficiency.

Authors:  L Webber; M Davies; R Anderson; J Bartlett; D Braat; B Cartwright; R Cifkova; S de Muinck Keizer-Schrama; E Hogervorst; F Janse; L Liao; V Vlaisavljevic; C Zillikens; N Vermeulen
Journal:  Hum Reprod       Date:  2016-03-22       Impact factor: 6.918

10.  Premature menopause in a multi-ethnic population study of the menopause transition.

Authors:  J L Luborsky; P Meyer; M F Sowers; E B Gold; N Santoro
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  3 in total

1.  Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.

Authors:  Ilhan Sanverdi; Cetin Kilicci; Ebru Cogendez; Cigdem Abide Yayla; Enis Ozkaya
Journal:  J Clin Lab Anal       Date:  2017-12-15       Impact factor: 2.352

Review 2.  The role of oxidative stress in ovarian aging: a review.

Authors:  Fei Yan; Qi Zhao; Ying Li; Zhibo Zheng; Xinliang Kong; Chang Shu; Yanfeng Liu; Yun Shi
Journal:  J Ovarian Res       Date:  2022-09-01       Impact factor: 5.506

3.  Evaluation inflammatory markers of hemogram parameters in primary ovarian insufficiency.

Authors:  Bülent Demir; Süreyya Sarıdaş Demir; Kübra Özkan Karacaer; Semir Paşa; Fatma Sılan
Journal:  Turk J Obstet Gynecol       Date:  2020-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.